Arca
Skip to content

SLAMF7: SLAM family member 7

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family.

  • Drugs that act on it: 2
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
ElotuzumabApprovedSLAM family member 7 inhibitorInhibitor—
Azintuxizumab vedotin—SLAM family member 7 binding agentBinding agent—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Plasma cell myeloma
0.60
Neoplasm
0.40
Rotator cuff syndrome
0.24
Delayed puberty
0.20
Abnormality of the skeletal system
0.19
Miyoshi myopathy
0.11
Autism
0.11
AL amyloidosis
0.10

Drugs and mechanisms are from ChEMBL CHEMBL3559386 (CC BY-SA 3.0). Gene name, function (UniProt Q9NQ25, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.